Karolinska Development AB, a publicly listed investment company, has appointed Viktor Drvota as its chief investment officer to help expand the company’s activities in the Nordic region. Dr Drvota joins Karolinska from SEB Venture Capital where he was head of life science. Prior to this, he was a practising cardiologist at Huddinge University Hospital in Stockholm for 11 years and also an associate professor in cardiology at the Karolinska Institutet.
Karolinska Development announced the appointment on 7 December 2015.
Copyright 2015 Evernow Publishing Ltd